Beginner's Mind

Beginner's Mind

Download on the App Store

All Beginner's Mind episodes

  • #51: Saara Inkinen - The Future of Tech Transfer in a Post-Pandemic World

    Tech Transfer describes the process to bring scientific inventions from the discovery stage into companies for translational and clinical R&D.

    To gain more insights into this area, I invited a tech transfer expert from the LSG2G Community to this conversation.

    Speaker in this Episode is Saara Inkinen, Nordic Catalyst.

    Dr. Inkinen is a technology transfer and innovation management specialist based in Vienna, Austria. She originally came from Finland and had her first position in the chemical industry already in 2000. 

    For more details on Dr. Inkinen’s education and professional experience, please have a look at her LinkedIn profile.

    The Company - Nordic Catalyst

    Nordic Catalyst is a technology transfer and innovation management company founded by Dr. Saara Inkinen in 2018. Nordic Catalyst is located in Austria, and it works with an international client base consisting of both research organizations and companies.

    Questions we discuss in the show:

    • What is Tech Transfer?
    • Why is it necessary to bring ideas from universities into startups and companies?
    • Is tech transfer biotech and pharma different from other tech areas?
    • What challenges solve tech transfer?
    • How has the environment changed with the pandemic?
    • And much more…

    Follow Saara Inkinen and Nordic Catalyst:

    • Saara Inkinen on Linkedin
    • Nordic Catalyst on Linkedin

    Shownotes:

    • Link to Article in the Member & Partner Community

    Timestamps:
    00:00 Introduction

    01:45 What is Tech Transfer

    02:30 The Tech Transfer Process

    04:05 Tech Transfer – Licensing, IP Sale and Startups

    05:00 Tech Transfer with Industrial Partners

    07:40 Why is Tech Transfer Necessary?

    13:20 Which Challenges Does TTO Face in the Life Science Networked Economy?

    16:37 How do different Skillsets Interact in Early Stage Development?

    19:35 Advantages and Disadvantages of the Startup Ecosystem for Deep Tech Companies

    23:10 How did the Pandemic Change the Environment for Tech Transfer

    27:17 How long does it take to turn a scientific idea into a finished product?

    30:52 What Challenges Exist in the Early Stage Development Field?

    33:40 How Do Business and Science Play Together?

    35:00 New Trends in Tech Transfer

    37:00 How Connected is the European Early Stage Industry?

    38:00 What is the First Step Towards Putting a scientific idea into a product?

    Podcast Links:
    Podcast Website: https://www.lifescienceget2gether.com/
    Community Partner: https://linktr.ee/lsg2g
    Christian Soschner: https://linktr.ee/soschner
    LSG2G Twitter: https://twitter.com/LGet2gether
    LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
    Podcast Episodes: https://pod.link/1493847125
    Episodes on YouTube:  https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV

    Send us Fan Mail

    Support the show

    Join the Podcast Newsletter: Link

    Your Next Move: Link

    42 min
  • #50: Dimitrios Tzalis - Insights Into Building CROs in Asia and in Europe

    In this conversation, we discuss the development of the European Pharma Eco-System, different business models, and what it takes to lead a company to success.

    Today’s speaker is Dimitrios Tzalis.
    In the 90s, he received a Ph.D. from the University of California, San Diego, a Master of Science in Chemistry from the University of Chicago, and a Master of Science in Biochemistry from Ball State University in Muncie, Indiana USA.

    1998 he returned to Germany to found Taros Chemicals GmbH & Co. KG.

    Questions we discuss in the show:

    • When and why did Dimitrios decide to found a novel company?
    • How did Dimitrios find the Right Business Model?
    • How did the industry evolve in India and Germany over the last two decades?
    • How do you see the future of the life science industry globally after the push that it got with Sars Cov 2?
    • And more…

    Timestamps:
    00:00 Introduction
    04:25 Introduction Dimitrios Tzalis
    05:45 How to Start a Life Science Company During the Dot.com Bubble Times
    08:15 The Decision to Start a Company Rather Than Applying for a Job
    10:15 How did the European Life Science Eco-System Look Like in the 1990s?
    12:54 Where to Get Inspiration for Writing a Business Plan?
    16:54 The Structure of the Pharmaceutical Industry in the 90s/early 2000s
    20:15 The  Life Science Economy 
    22:55 The Different Mindsets  to Bringing an Idea to Market
    31:05 How to Fund Early-Stage Development Companies
    36:30 From Founding a Company in Germany to  India
    41:10 How Technology Changed Collaboration in the Last Two Decades
    44:25 Development of Cultural Similarities and Differences Between India and Germany Since 2000
    47:00 Is there a Global Convergence of Business Culture?
    52:17 The Pharma Industry in India – 2000-2021
    55:20 The Future of the Pharmaceutical Industry in India
    57:40 How Are Problems Approached in India vs. Europe?
    01:01:20 How Entrepreneurs Approach Problems
    01:03:15 Entrepreneurship & Passion
    01:06:00 The Role of Passion
    01:10:20 The Role of Leadership 
    01:12:26 Teamplay in Companies
    01:14:54 Life Science Business Models
    01:20:10 The Private and The Public Life Science World
    01:25:00 The Future of the Life Science Industry 
    01:42:50 The European Culture Around Entrepreneurship
    01:50:00 Short-Term Thinking and Long Term Planning
    01:54:30 What is the Most Important Advice to First Time Founders

    Follow Dimitrios Tzalis and Taros:

    • Dimitrios Tzalis
    • Taros

    Shownotes:

    • Video to the Episode
    • Article to the Episode

    Podcast Links:
    Podcast Website: https://www.lifescienceget2gether.com/
    Community Partner: https://linktr.ee/lsg2g
    Christian Soschner: https://linktr.ee/soschner
    LSG2G Twitter: https://twitter.com/LGet2gether
    LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
    Podcast Episodes: https://pod.link/1493847125
    Episodes on YouTube:  https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV

    Send us Fan Mail

    Support the show

    Join the Podcast Newsletter: Link

    Your Next Move: Link

    1 hr 58 min
  • #49: Andrea Sommer - Marrying Deeptech with IP Strategy

    Here is my conversation with Andrea Sommer about the advantages of patents for private deep-tech companies.

    Timestamps:
    For those who want to listen to specific parts of the episode, here are the timestamps:

    00:00 Opening Christian Soschner
    02:00 Intro Andrea Sommer – Importance of Patents
    03:48 The Role of Patents in Deep Tech Companies – Understanding the Importance of Patent Processes
    13:51 What is the right point in time to file a patent application?
    15:57 Patent process in Europe
    24:25 Patents – A Once in a Lifetime Event or a Process?
    35:00 The importance of getting the right information for the first filing
    37:10 The Reasons for an FTO Analysis from the Patent Attorney’s Perspective
    41:40 When is the right time for an FTO Analysis
    46:00 More Details on the Process of FTO Analysis – Better Late than Never?
    51:15 How to Implement Patent and FTO Processes into the Organisation
    57:27 Patent Infringement
    01:02:10 Possibilities of Compulsory Licenses
    01:07:15 A Brief History of Patent Laws…
    01:09:20 … and The Future Of Patent Laws
    01:15:00 The Future of Patents and Licenses
    01:23:00 Patents and Sars CoV 2 – Would giving up patent rights by governmental enforcement tackle the right problem?
    01:27:40 Tesla put all Patents into the Public Domain 2014 – Does that make sense?
    01:33:20 The Role of Patents in Startups
    01:40:30 Is there a difference between US Entrepreneurs and their European counterparts?
    01:44:00  Perception of Entrepreneurship
    01:49:00 How to Collaborate with Big Corporations as an SME
    01:53:00 Patents and Investors

    Episode Links:
    Article to the Episode: https://lsg2g.substack.com/p/marrying-deeptech-with-ip-strategy-7f8
    Youtube: https://youtu.be/yjqq6P2eWVc
    Andrea Sommer: https://www.linkedin.com/in/dr-andrea-sommer/

    Podcast Links:
    Podcast Website: https://www.lifescienceget2gether.com/
    Community Partner: https://linktr.ee/lsg2g
    Christian Soschner: https://linktr.ee/soschner
    LSG2G Twitter: https://twitter.com/LGet2gether
    LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
    Podcast Episodes: https://pod.link/1493847125
    Episodes on YouTube:  https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV

    Send us Fan Mail

    Support the show

    Join the Podcast Newsletter: Link

    Your Next Move: Link

    2 hr
  • #48: Kurt Höller & Joy Cürten EIT - Health & The International Healthtech Revolution

    Here is my conversation with Kurt Höller and Joy Cürten from EIT Health about the health tech revolution in Europe and the Rest of the World.

    Episode Links:
    Article to the Episode: https://lsg2g.substack.com/p/eit-health-and-the-international-514
    Youtube:  https://youtu.be/OnQrvbgcO8Y
    Kurt Höller: https://www.linkedin.com/in/hoeller/
    Joy Cürten: https://www.linkedin.com/in/joy-c%C3%BCrten-a8977241/
    EIT Health: https://www.linkedin.com/company/eithealth/

    Podcast Links:
    Podcast Website: https://www.lifescienceget2gether.com/
    Community Partner: https://linktr.ee/lsg2g
    Christian Soschner: https://linktr.ee/soschner
    LSG2G Twitter: https://twitter.com/LGet2gether
    LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
    Podcast Episodes: https://pod.link/1493847125
    Episodes on YouTube:  https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV

    Timestamps:
    For those who want to listen to specific parts of the episode, here are the timestamps:

    (00:00) Opening Christian Soschner
    (04:19) Introduction Joy Cürten
    (08:47) Introduction Kurt Höller
    (15:08) How Much Funding is Needed to Start an Initiative Like EIT Health
    (16:12) The Early Days of EIT Health
    (19:31) How Does EIT Operate?
    (21:05) Initiatives at EIT Health
    (26:33) Classification of Healthtech Companies
    (32:53) How did the pandemic shape the health tech sector in Europe?
    (50:00) Cultural Differences Between Entrepreneurship in the US and Europe
    (58:40) Development of Open Innovation and Communication in Europe
    (01:08:00) How the Pandemic changed the European Landscape
    (01:15:00) What Policy Changes Would Help the European Healthtech Sector?
    (01.21:00) EIC, EIT, and EIF – How The Institutions Work Together with Corporate Investors and VCs

    Referenced in the show:
    Sachs Forum Basel 2021: https://www.sachsforum.com/21bef-about.html
    Weltmarktführer Innovation Day 2021: https://www.weltmarktfuehrer-innovationday.de/, https://www.fau.de/innovator-of-tomorrow-award/
    e-Health Investment Forum 2021 https://echalliance.com/event/bhh-is-calling-startups-working-on-ai-in-healthcare/
    EHC Digital Health Semifinal 2021 https://eithealth.eventscase.com/EN/catapult_semifinals20214yFN 2022, https://www.4yfn.com/
    MedtecLIVE 2022 https://www.medteclive.com/en/exhibitors/participation/start-ups
    EIT Health Summit 2022 https://eithealth.eu/event/save-the-date-eit-health-summit-2022/

    Send us Fan Mail

    Support the show

    Join the Podcast Newsletter: Link

    Your Next Move: Link

    1 hr 42 min
  • #47: Sebastien Groyer - 7 Tales from 20 years of Deep Tech Life Science Venture Capital Investment

    Here is my conversation with Sebastien Groyer, Entrepreneur and Venture Capitalist

    Episode Links:
    Article to the Episode: https://lsg2g.substack.com/p/7-tales-from-20-years-of-deep-tech-42f
    Youtube: https://youtu.be/Ni3mEDM7-_c
    Sebastien Groyer: https://www.linkedin.com/in/sebastien-groyer-2438548/

    Podcast Links:
    Podcast Website: https://www.lifescienceget2gether.com/
    Community Partner: https://linktr.ee/lsg2g
    Christian Soschner: https://linktr.ee/soschner
    LSG2G Twitter: https://twitter.com/LGet2gether
    LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
    Podcast Episodes: https://pod.link/1493847125
    Episodes on YouTube:  https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV

    Timestamps:
    For those who want to listen to specific parts of the episode, here are the timestamps:

    00:00 Introduction

    02:35 How do VCs view planning in companies?

    05:59 How to Approach Investors when Plans Change

    11:00 What are Target Companies of VCs?

    15:15 Are VCs Going for First Movers or Rather Established Markets?

    19:30 How Detailed Should  Business Plans be when Pitching to VCs?

    23:50 Storytelling – From Rough to Detail

    27:15 The Reality of VC Life

    34:40 How Often Can You Follow Up with VCs before Ending Up on a Blacklist

    38:54 What is the Right Time to Approach VCs?

    40:40 How do VCs view companies in Fundraising Mode?

    46:10 The Fundraising Process in a Company

    48:15 Is the Fundraisngprocess Transactional, or do Relationships matter?

    51:00 Fundraising – Similarities and Differences between the US and the European Approach

    56:50 Entrepreneurship and Investors – Lifestyle or a Job?

    01:00:00 The Role of Money in Different Societies

    01:04:00 Why Do VCs Search for Exits?

    01:11:00 Valuation Expectations of VCs

    01:14:00 It is all about growth

    01:19:00 When Does it Make Sense to Reach out to VCs?

    01:23:00 Differences in the Value of Information in the B2B and B2C world

    01:27:00 The Pros and Cons of Being an Investor or Entrepreneur

    01:30:00 Spirituality, Investment, and Entrepreneurship

    01:34:30 What is the most important thing to consider when reaching out to VCs?

    Send us Fan Mail

    Support the show

    Join the Podcast Newsletter: Link

    Your Next Move: Link

    1 hr 42 min
  • #46: Wolfgang Kienreich - An Introduction to Know-Center: How Artificial Intelligence Will Change all Industries

    Here is my conversation with Wolfgang Kienreich, CBO of Know-Center.

    Episode Links:
    Article to the Episode: https://lsg2g.substack.com/p/46-an-introduction-to-know-center
    Youtube: https://youtu.be/eTU5zROX5E4
    Wolfgang Kienreich: https://www.linkedin.com/in/wolfgang-kienreich-8350b899/
    Know Center: https://www.linkedin.com/company/know-center/

    Podcast Links:
    Podcast Website: https://www.lifescienceget2gether.com/
    Community Partner: https://linktr.ee/lsg2g
    Christian Soschner: https://linktr.ee/soschner
    LSG2G Twitter: https://twitter.com/LGet2gether
    LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
    Podcast Episodes: https://pod.link/1493847125
    Episodes on YouTube:  https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV

    Timestamps:
    For those who want to listen to specific parts of the episode, here are the timestamps:

    00:00 Introduction
    01:45 What is Fact and What is Fiction in Artificial Intelligence?
    05:45 Artificial Intelligence in Autonomous Driving
    07:30 AI in Language Translation and Understanding
    11:00 AI in Education
    12:20 How AI Improves Drug Discovery and Development
    15:00 Analyzing Health Data under GDPR
    16:55 How Wearable Technology Can Support Scientists to Get More Insights into the Development of Diseases
    18:15 European North Star Projects in AI
    20:45 Starting Point for SME Entrepreneurs in AI
    24:00 The History of the KNOW Center
    27:20 Industry Partners of the KNOW Center and Use Cases Developed with them
    31:30 How Does AI Affect Labour?
    34:05 Innovation Speed and AI
    36:00 The Role of AI in Search
    41:00 AI and Recommendation Management
    43:00 Potential in Assisted Living
    44:30 What is a Digital Twin?
    47:35 Recommendation to SMEs to Approach KNOW Center

    Send us Fan Mail

    Support the show

    Join the Podcast Newsletter: Link

    Your Next Move: Link

    52 min
  • #45: Jama Nateqi - 5 Habits of Successful Entrepreneurs

    Here is my conversation with Jama Nateqi, CEO of Symptoma.

    Episode Links:
    Article to the Episode: https://lsg2g.substack.com/p/45-hidden-secrets-to-successful-entrepreneurship
    Youtube: https://youtu.be/VOBc7pfqWOI
    Jama Nateqi: https://www.linkedin.com/in/jama-nateqi/
    Symptoma: https://www.linkedin.com/company/symptoma/

    Podcast Links:
    Podcast Website: https://www.lifescienceget2gether.com/
    Community Partner: https://linktr.ee/lsg2g
    Christian Soschner: https://linktr.ee/soschner
    LSG2G Twitter: https://twitter.com/LGet2gether
    LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
    Podcast Episodes: https://pod.link/1493847125
    Episodes on YouTube:  https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV

    Timestamps:
    For those who want to listen to specific parts of the episode, here are the timestamps:

    00:00:00 Kick-Off
    00:02:12 Intro Jama Nateqi – Give up your Freedom to gain Freedom
    00:03:47 Sleeping Habit
    00:04:53 Benefits of Waking Up Early
    00:05:43 What Is More Important – Quality or Quantity of Sleep?
    00:14:30 Why Making Your Bed Matters
    00:17:31 How to Achieve Peak Performance
    00:18:25 Lack of Sleep and its Impact on IQ
    00:19:20 Symptoma and Working Hours
    00:21:00 Meditation
    00:30:00 Deep Work & Digital Drugs
    00:36:00 Screentime – Modern Technology – Blessing or a Burden?
    00:45:00 Does Free Will Exist?
    00:53:00 Bad and Good – Yin And Yang
    00:56:00 The Power of Habit
    01:04:00 The Amazon Case 
    01:06:30 Never Stop Learning
    01:08:00 The Role of Exercising
    01:12:30 Health Benefits of Exercising
    01:16:00 The Benefits of “Don’t Demand too Much of Yourself.”
    01:20:00 New Year’s Resolutions
    01:23:00 Setting Goals in the Right Size
    01:26:00 The Habits of Setting Daily Goals & Time blocking
    01:33:00 Attitude to Failure
    01:35:00 About Nutrition
    01:39:25 Why conserving willpower is crucial for deep work
    01:43:00 Journaling
    01:45:00 Meaning of Life & Purpose of Businesses
    01:55:00 Finding the Right Team for a Vision
    02:06:00 What is Your Biggest Success in Life?
    02:10:00 What is the most important habit?

    Send us Fan Mail

    Support the show

    Join the Podcast Newsletter: Link

    Your Next Move: Link

    2 hr 15 min
  • #44: Tero Weckroth - Private and Public Investments - Similarities and Differences from the Crowdfunding and Angel Perspective

    Here is the conversation with Tero Weckroth, Business Angel and Investment Expert from Finland about Public and Private Investments.

    Episode Links:
    Article to the Episode: https://lsg2g.substack.com/p/44-private-and-public-investments
    Video to the Episode: https://youtu.be/7WDHWOyaPQQ
    Tero Weckroth: https://www.linkedin.com/in/tero-weckroth-5b927/
    Chessboxing: https://www.nordicchessboxing.com/

    Podcast Links:
    Podcast Website: https://www.lifescienceget2gether.com/
    Community Partner: https://linktr.ee/lsg2g
    Christian Soschner: https://linktr.ee/soschner
    LSG2G Twitter: https://twitter.com/LGet2gether
    LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
    Podcast Episodes: https://pod.link/1493847125
    Episodes on YouTube:  https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV

    Timestamps:
    For those who want to listen to specific parts of the episode, here are the timestamps:

    (0:00) Opening words
    (0:30) Introduction Tero Weckroth
    (3:00) Life Science in Finland
    (8:30) Life Science Investments for Business Angels
    (22:00) Alzheimer Drug Development and Diagnostics – Biogen and Combinostics
    (26:40) What is the Right Pricing for Drugs on the Market?
    (30:00) Availability of Capital for Early-Stage Drug Development
    (33:00) Importance of a Team
    (38:00) Public Investments and Crowdfunding
    (44:00) Risk Management for Investors
    (46:00) Differences between Privat and Public Investment and Crowdfunding
    (49:30) Reddit – New Development on the Stock Market
    (01:00:00) New Macroeconomic Era?
    (01:06:00) Cash, Gold, or Digital Gold?
    (01:15:00) Technological Evolvement in the Investment Banking World
    (01:20:00) Effects of the Pandemic on Regulations
    (01:25:00) Cryptocurrencies - Bitcoin, Cardano, Etherum & co.

    Send us Fan Mail

    Support the show

    Join the Podcast Newsletter: Link

    Your Next Move: Link

    1 hr 37 min
  • #43: Tilmann Buerckstuemmer and Thomas Moser - Gene-Editing - The Next Game-Changing Technology?

    Thomas Moser and Tilmann Buerckstuemmer lead the Austrian Life Science Company Aelian Biotechnology.

    Episode Links:
    Article to the Episode: https://lsg2g.substack.com/p/gene-editing-the-next-game-changing-d3f
    Video to the Episode: https://youtu.be/3bf7ChYUHLE
    Aelian Biotechnology: https://aelian.bio/
    Thomas Moser: https://www.linkedin.com/in/thomas-moser-79819a5/
    Tilmann Buerckstuemmer: https://www.linkedin.com/in/tilmann-burckstummer-19b65949/

    Podcast Links:
    Podcast Website: https://www.lifescienceget2gether.com/
    Community Partner: https://linktr.ee/lsg2g
    Christian Soschner: https://linktr.ee/soschner
    LSG2G Twitter: https://twitter.com/LGet2gether
    LSG2G Linkedin: https://www.linkedin.com/company/life-science-get2gether
    Podcast Episodes: https://pod.link/1493847125
    Episodes on YouTube:  https://www.youtube.com/playlist?list=PLlZfrwd6iXrQ3LIANISUpP22seS2CsCEV

    Timestamps:
    For those who want to listen to specific parts of the episode, here are the timestamps:

    (00:00) Introduction
    (02:23) Introduction Thomas Moser
    (05:45) Introduction Tilmann Bürckstümmer
    (08:40) Aelian Biotechnology
    (10:20) The Science Behind Aelian
    (17:50) Life Science Business Model
    (27:00) How to Setup Business Relationships in Life Science
    (34:35) Gene Editing - Why Did it Create Such a Hype?
    (41:00) History of Gene Editing with Insights Into CRISPR/Cas9
    (45:30) Vienna - Part of The CRISPR Community
    (47:50) IP of CRISPR
    (50:00) CRISPR - Real Life Use Cases
    (55:05) CRISPR in Cancer Research
    (59:20) Are Genetically Altered Human Beings Possible?
    (01:04:20) Genetically Enhanced Human Beings - Reality or SciFi?
    (01:08:00) Gene Editing and its Role in Agriculture
    (01:12:00) SARS-CoV-2 - What Role Did CRISPR Play in Fighting the Pandemic?
    (01:12:20) CRISPR Screen for SARS-CoV-2 - Technology of Aelian Biotechnology
    (01:15:00) Drug Discovery for SARS-CoV-2 with CRISPR
    (01:18:00) Fundraising for Life Science Companies
    (01:27:00) Comparison of the Investment Culture in Europe and the United States
    (01:31:00) Major Players in the CRISPR Field
    (01:32:00) CRISPR - IP Landscape
    (01:44:00) Final Question: Advice for First Time Entrepreneurs

    Send us Fan Mail

    Support the show

    Join the Podcast Newsletter: Link

    Your Next Move: Link

    1 hr 50 min
  • #42: Johannes Sarx and Philipp Hainzl - LISA - Life Science in Austria

    Have you ever wondered what role the small country Austria - located in the center of Europe - plays in Life Science?

    Then listen to the managing directors of LISAvienna, Johannes Sarx, and Philipp Hainzl. 

    LISAvienna is a joint life science platform operated by Austria Wirtschaftsservice and the Vienna Business Agency. On behalf of the Austrian Federal Ministry for Digital and Economic Affairs and the City of Vienna, it contributes to the advancement of life sciences in Vienna. 

    LISAvienna supports innovative biotech, pharmaceutical, medical device, and digital health companies in Vienna that develop and market new products, services, and processes. The platform links these companies with development partners and key customers. 

    As a central knowledge carrier, LISAvienna provides input for decisions to advance the life sciences in Vienna and contributes to positioning the city of Vienna as one of the leading European innovation centers.

    If you want to learn more about the Life Science Hot Spots in the center of Europe, then this episode is for you.

    In this talk we discussed the situation of Life Science in Austria and covered topics like

    • Public Funding
    • Life Science Conferences
    • Infrastructure
    • Access to global talent and
    • private funding as well as the pharma industry.

    Join us for a colloquial chat over Life Science and Entrepreneurship.

    Conference in person in fall in Austria as discussed in the Episode:

    The European Forum for Industrial Biotechnology and the Bioeconomy (EFIB)will take place in #Vienna this year, and is themed “Delivering the EU Green Deal: Industrial biotechnology into business”. Join the dialogue on how biotech can enable a more circular and sustainable future. As EFIB’s local partner, LISAvienna is looking forward to connecting you to experts in the region. Mark your calendar for October 6-7, 2021 and join us at Austria Center Vienna - Internationales Kongresszentrum.

    This is a great opportunity to grow your network.

    Learn more about the regional expertise, potential partners and new products and services online. Many of these breakthrough innovations will be showcased at EFIB in Vienna.
    Image: acv.at / begehungen.de
    https://lnkd.in/euT5eRe

    Speaker:
    Christian Soschner
    Johannes Sarx
    Philipp Hainzl

    Organizations:
    CS Life Science Invest
    LISAvienna

    Send us Fan Mail

    Support the show

    Join the Podcast Newsletter: Link

    Your Next Move: Link

    47 min